Live Earnings Conference Call: Dare Bioscience will host a live Q3 2026 earnings call on November 16, 2026 at 4:30PM ET. NASDAQ:DARE Dare Bioscience Q3 2026 Earnings Date & Estimates $0.66 0.00 (0.00%) Closing price 11/13/2026 04:00 PM EasternExtended Trading$0.64 -0.02 (-3.41%) As of 11/13/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Dare Bioscience is estimated to report Q3 2026 earnings on Monday, November 16, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 16, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) Live Call not available Upcoming EventEarnings Conference CallDare Bioscience Q3 202600:00 / 00:00Live Transcript Follow Audio What Analysts Expect from Dare Bioscience in Q3 2026Dare Bioscience is expected to post earnings of -$0.1267 per share on revenue of $2.04 million. In the same quarter a year earlier Dare Bioscience reported -$0.28 per share on revenue of $2.26 thousand. Dare Bioscience last reported on August 13, 2026, posting -$0.20 per share and beating the -$0.2967 consensus estimate. Dare Bioscience has beaten the consensus EPS estimate in 8 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.1267Expected Revenue$2.04 millionPrior-Year EPS-$0.28Prior-Year Revenue$2.26 thousandExpected Revenue Growth+89,997.3%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.20 (Beat by +$0.0967)Last Quarter Revenue$187.55 thousandEPS Beat Rate8 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Dare Bioscience Q3 2026 Earnings FAQ When does Dare Bioscience report Q3 2026 earnings? Dare Bioscience (NASDAQ:DARE) is estimated to report Q3 2026 earnings on Monday, November 16, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Dare Bioscience's Q3 2026 earnings call? Dare Bioscience's Q3 2026 earnings conference call is scheduled for Monday, November 16, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Dare Bioscience? Analysts expect Dare Bioscience to post earnings of -$0.1267 per share for Q3 2026. How much revenue is Dare Bioscience expected to report? The consensus revenue estimate for Dare Bioscience is $2.04 million for Q3 2026. Dare Bioscience Earnings HeadlinesDare Bioscience Expands Product Launches as Contraceptive and HPV Trial Data ApproachNovember 14 at 2:00 AM | americanbankingnews.comDare Bioscience (DARE) Expected to Release Earnings on ThursdayNovember 11, 2026 | americanbankingnews.comURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards urges homeowners to check the map and see whether one is near them. Families in Georgia have been forced to sell, entire Ohio neighborhoods are being torn down, and nearly 50,000 Lake Tahoe residents face losing power. Rickards advised the Pentagon and the U.S. intelligence community for decades. He says one man outside Washington can stop it. | Paradigm Press (Ad)Daré Bioscience to Host Third Quarter 2026 Financial Results and Company Update Conference Call and Webcast on November 16, 2026November 10, 2026 | globenewswire.comDaré Bioscience Releases Next Episode in “CEO Corner” Video SeriesNovember 9, 2026 | globenewswire.comDaré Bioscience to Present at Stifel’s 2026 Healthcare ConferenceNovember 4, 2026 | finance.yahoo.comSee More Dare Bioscience Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Dare Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Dare Bioscience and other key companies, straight to your email. Email Address About Dare BioscienceDaré Bioscience is a clinical-stage biopharmaceutical company focused on developing therapies and products for women’s health. Its work spans areas including contraception, vaginal health and sexual health, with an emphasis on addressing conditions and needs that have had limited treatment options. The company’s product candidates include Ovaprene, a hormone-free, monthly-use vaginal contraceptive, and investigational treatments for conditions such as female sexual arousal disorder. These candidates remain in development and are not approved for general use. Daré’s XACIATO, a vaginal gel for bacterial vaginosis, received U.S. Food and Drug Administration approval in 2021; the company later licensed commercialization rights to Organon. Daré is based in San Diego, California, and its leadership includes President and Chief Executive Officer Sabrina Martucci Johnson.View Dare Bioscience ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles 3 Building-Materials Stocks Rallying While Homebuilders Struggle to Find BuyersMarketBeat Week in Review – 11/9 - 11/13Nu Holdings Earnings Show a Compounder Priced Like a Brazil BetCerebras Q3 Results: How Much More Proof Does Wall Street Need?Applied Materials Beats and Raises, But Investors Stay Unconvinced3 Power and Grid Stocks That Could Keep Growing Even if AI Spending SlowsYETI Beat on Earnings, But Its Sales Tell a Different Story Upcoming Earnings Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.